Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update
Authors
Keywords
-
Journal
JOURNAL OF GENERAL VIROLOGY
Volume 98, Issue 12, Pages 2895-2911
Publisher
Microbiology Society
Online
2017-11-16
DOI
10.1099/jgv.0.000980
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oncolytic Maraba Virus MG1 as a Treatment for Sarcoma
- (2017) Fabrice Le Boeuf et al. INTERNATIONAL JOURNAL OF CANCER
- Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus
- (2017) Sébastien A. Felt et al. JOURNAL OF VIROLOGY
- Chikungunya, Influenza, Nipah, and Semliki Forest Chimeric Viruses with Vesicular Stomatitis Virus: Actions in the Brain
- (2017) Anthony N. van den Pol et al. JOURNAL OF VIROLOGY
- Inhibitory Receptors Induced by VSV Viroimmunotherapy Are Not Necessarily Targets for Improving Treatment Efficacy
- (2017) Kevin G. Shim et al. MOLECULAR THERAPY
- Oncolytic VSV Primes Differential Responses to Immuno-oncology Therapy
- (2017) Nicholas M. Durham et al. MOLECULAR THERAPY
- Oncolytic Virotherapy: A Contest between Apples and Oranges
- (2017) Stephen J. Russell et al. MOLECULAR THERAPY
- Activation of Nrf2 Signaling Augments Vesicular Stomatitis Virus Oncolysis via Autophagy-Driven Suppression of Antiviral Immunity
- (2017) David Olagnier et al. MOLECULAR THERAPY
- Curcumin promotes the oncoltyic capacity of vesicular stomatitis virus for the treatment of prostate cancers
- (2017) Dylan J. Fehl et al. VIRUS RESEARCH
- NK-Cell Recruitment Is Necessary for Eradication of Peritoneal Carcinomatosis with an IL12-Expressing Maraba Virus Cellular Vaccine
- (2017) Almohanad A. Alkayyal et al. Cancer Immunology Research
- Oncolytic Recombinant Vesicular Stomatitis Virus (VSV) Is Nonpathogenic and Nontransmissible in Pigs, a Natural Host of VSV
- (2017) Lauro Velazquez-Salinas et al. Human Gene Therapy Clinical Development
- Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy
- (2017) Christian Bressy et al. Molecular Therapy-Oncolytics
- Enhancing the Oncolytic Activity of CD133-Targeted Measles Virus: Receptor Extension or Chimerism with Vesicular Stomatitis Virus Are Most Effective
- (2017) Dina Kleinlützum et al. Frontiers in Oncology
- Hepatitis C virus core protein enhances hepatocellular carcinoma cells to be susceptible to oncolytic vesicular stomatitis virus through down-regulation of HDAC4
- (2016) Jeong Moon et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- A mathematical approach to virus therapy of glioblastomas
- (2016) Victor Lopez de Rioja et al. Biology Direct
- Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy
- (2016) E Ilett et al. GENE THERAPY
- Murine Tumor Models for Oncolytic Rhabdo-Virotherapy
- (2016) Theresa Falls et al. ILAR JOURNAL
- Perfusion Pressure Is a Critical Determinant of the Intratumoral Extravasation of Oncolytic Viruses
- (2016) Amber Miller et al. MOLECULAR THERAPY
- Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model
- (2016) Lianwen Zhang et al. MOLECULAR THERAPY
- A PTENtial cause for the selectivity of oncolytic viruses?
- (2016) Brian R Champion et al. NATURE IMMUNOLOGY
- Oncolytic virus synergizes with Smac mimetic compounds to induce rhabdomyosarcoma cell death in a syngeneic murine model
- (2016) Christine C. Dobson et al. Oncotarget
- Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus
- (2016) Eric Hastie et al. Oncotarget
- Constrained evolvability of interferon suppression in an RNA virus
- (2016) Raquel Garijo et al. Scientific Reports
- Safety Studies in Tumor and Non-Tumor-Bearing Mice in Support of Clinical Trials Using Oncolytic VSV-IFNβ-NIS
- (2016) Lianwen Zhang et al. Human Gene Therapy Clinical Development
- Complement inhibition enables tumor delivery of LCMV glycoprotein pseudotyped viruses in the presence of antiviral antibodies
- (2016) Laura Evgin et al. Molecular Therapy-Oncolytics
- N-Myc expression enhances the oncolytic effects of vesicular stomatitis virus in human neuroblastoma cells
- (2016) Juan C Corredor et al. Molecular Therapy-Oncolytics
- Application of interferon modulators to overcome partial resistance of human ovarian cancers to VSV-GP oncolytic viral therapy
- (2016) Catherine Dold et al. Molecular Therapy-Oncolytics
- Oncolytic vesicular stomatitis virus expressing interferon-σ has enhanced therapeutic activity
- (2016) Marie-Claude Bourgeois-Daigneault et al. Molecular Therapy-Oncolytics
- Into the clinic: Talimogene laherparepvec (T-VEC), a first-in-class intratumoral oncolytic viral therapy
- (2016) Hasan Rehman et al. Journal for ImmunoTherapy of Cancer
- Oncolytic Viruses: Therapeutics With an Identity Crisis
- (2016) Caroline J. Breitbach et al. EBioMedicine
- Immunovirotherapy with vesicular stomatitis virus and PD-L1 blockade enhances therapeutic outcome in murine acute myeloid leukemia
- (2015) W. Shen et al. BLOOD
- STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma
- (2015) S Marozin et al. CANCER GENE THERAPY
- The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
- (2015) Kathleen M. Mahoney et al. CLINICAL THERAPEUTICS
- Livin modulates the apoptotic effects of vesicular stomatotitis virus in lung adenocarcinoma
- (2015) GUI-HONG LIU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Definitive Management of Oligometastatic Melanoma in a Murine Model Using Combined Ablative Radiation Therapy and Viral Immunotherapy
- (2015) Miran Blanchard et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Retargeting Oncolytic Vesicular Stomatitis Virus to Human T-Cell Lymphotropic Virus Type 1-Associated Adult T-Cell Leukemia
- (2015) Dillon Betancourt et al. JOURNAL OF VIROLOGY
- Interferon Beta and Interferon Alpha 2a Differentially Protect Head and Neck Cancer Cells from Vesicular Stomatitis Virus-Induced Oncolysis
- (2015) Marlena M. Westcott et al. JOURNAL OF VIROLOGY
- Changes in Susceptibility to Oncolytic Vesicular Stomatitis Virus during Progression of Prostate Cancer
- (2015) Nanmeng Yu et al. JOURNAL OF VIROLOGY
- Lassa-Vesicular Stomatitis Chimeric Virus Safely Destroys Brain Tumors
- (2015) Guido Wollmann et al. JOURNAL OF VIROLOGY
- Adapted ECHO-7 virus Rigvir immunotherapy (oncolytic virotherapy) prolongs survival in melanoma patients after surgical excision of the tumour in a retrospective study
- (2015) Simona Doniņa et al. MELANOMA RESEARCH
- PET Imaging of Oncolytic VSV Expressing the Mutant HSV-1 Thymidine Kinase Transgene in a Preclinical HCC Rat Model
- (2015) Kim A Muñoz-Álvarez et al. MOLECULAR THERAPY
- Combination viroimmunotherapy with checkpoint inhibition to treat glioma, based on location-specific tumor profiling
- (2015) Julia V. Cockle et al. NEURO-ONCOLOGY
- Vesicular stomatitis virus is a potent agent for the treatment of malignant ascites
- (2015) YI ZHOU et al. ONCOLOGY REPORTS
- Breaking resistance of pancreatic cancer cells to an attenuated vesicular stomatitis virus through a novel activity of IKK inhibitor TPCA-1
- (2015) Marcela Cataldi et al. VIROLOGY
- Attenuation of vesicular stomatitis virus infection of brain using antiviral drugs and an adeno-associated virus-interferon vector
- (2015) Guido Wollmann et al. VIROLOGY
- An unexpected inhibition of antiviral signaling by virus-encoded tumor suppressor p53 in pancreatic cancer cells
- (2015) Eric Hastie et al. VIROLOGY
- Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus
- (2015) Sébastien A. Felt et al. VIROLOGY
- Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing
- (2015) Rozanne Arulanandam et al. Nature Communications
- Vesicular stomatitis virus expressing interferon-β is oncolytic and promotes antitumor immune responses in a syngeneic murine model of non-small cell lung cancer
- (2015) Manish R. Patel et al. Oncotarget
- Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinity
- (2015) Camilo Ayala Breton et al. Molecular Therapy-Oncolytics
- Evidence for differential viral oncolytic efficacy in an in vitro model of epithelial ovarian cancer metastasis
- (2015) Jessica G Tong et al. Molecular Therapy-Oncolytics
- Re-engineering Vesicular Stomatitis Virus to Abrogate Neurotoxicity, Circumvent Humoral Immunity, and Enhance Oncolytic Potency
- (2014) A. Muik et al. CANCER RESEARCH
- Suppression of autophagic genes sensitizes CUG2-overexpressing A549 human lung cancer cells to oncolytic vesicular stomatitis virus-induced apoptosis
- (2014) WARAPORN MALILAS et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Faster Replication and Higher Expression Levels of Viral Glycoproteins Give the Vesicular Stomatitis Virus/Measles Virus Hybrid VSV-FH a Growth Advantage over Measles Virus
- (2014) C. Ayala-Breton et al. JOURNAL OF VIROLOGY
- Vesiculovirus Neutralization by Natural IgM and Complement
- (2014) M. Z. Tesfay et al. JOURNAL OF VIROLOGY
- Type III Interferon Attenuates a Vesicular Stomatitis Virus-Based Vaccine Vector
- (2014) R. C. Guayasamin et al. JOURNAL OF VIROLOGY
- Bacterial-Mediated Knockdown of Tumor Resistance to an Oncolytic Virus Enhances Therapy
- (2014) Michelle Cronin et al. MOLECULAR THERAPY
- The Strength of the T Cell Response Against a Surrogate Tumor Antigen Induced by Oncolytic VSV Therapy Does Not Correlate With Tumor Control
- (2014) Valérie Janelle et al. MOLECULAR THERAPY
- Maraba MG1 Virus Enhances Natural Killer Cell Function via Conventional Dendritic Cells to Reduce Postoperative Metastatic Disease
- (2014) Jiqing Zhang et al. MOLECULAR THERAPY
- Oncogenic Ras inhibits IRF1 to promote viral oncolysis
- (2014) Y Komatsu et al. ONCOGENE
- Experimental Evolution of an Oncolytic Vesicular Stomatitis Virus with Increased Selectivity for p53-Deficient Cells
- (2014) Raquel Garijo et al. PLoS One
- Using Targeted Virotherapy to Treat a Resistant Ewing Sarcoma Model: From the Bedside to the Bench and Back
- (2014) Hesham Abdelbary et al. TheScientificWorldJOURNAL
- MUC1: a multifaceted oncoprotein with a key role in cancer progression
- (2014) Sritama Nath et al. TRENDS IN MOLECULAR MEDICINE
- Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing Antibodies
- (2014) Darija Muharemagic et al. Molecular Therapy-Nucleic Acids
- Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacy
- (2014) Amber Miller et al. Molecular Therapy-Oncolytics
- Cancer upregulated gene 2, a novel oncogene, confers resistance to oncolytic vesicular stomatitis virus through STAT1-OASL2 signaling
- (2013) W Malilas et al. CANCER GENE THERAPY
- Meningeal myeloma deposits adversely impact the therapeutic index of an oncolytic VSV
- (2013) D N Yarde et al. CANCER GENE THERAPY
- Overcoming cancer cell resistance to VSV oncolysis with JAK1/2 inhibitors
- (2013) D Escobar-Zarate et al. CANCER GENE THERAPY
- Myeloid-Derived Suppressor Cells as a Vehicle for Tumor-Specific Oncolytic Viral Therapy
- (2013) S. Eisenstein et al. CANCER RESEARCH
- Oncolytic vesicular stomatitis virus and bortezomib are antagonistic against myeloma cells in vitro but have additive anti-myeloma activity in vivo
- (2013) Danielle N. Yarde et al. EXPERIMENTAL HEMATOLOGY
- Engineering a serum-resistant and thermostable vesicular stomatitis virus G glycoprotein for pseudotyping retroviral and lentiviral vectors
- (2013) B-Y Hwang et al. GENE THERAPY
- Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer
- (2013) Yu-Ping Liu et al. GYNECOLOGIC ONCOLOGY
- Preclinical safety and activity of recombinant VSV-IFN-β in an immunocompetent model of squamous cell carcinoma of the head and neck
- (2013) Vittal V. S. Kurisetty et al. HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK
- Cancer upregulated gene 2, a novel oncogene, enhances migration and drug resistance of colon cancer cells via STAT1 activation
- (2013) WARAPORN MALILAS et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Molecular determinants of susceptibility to oncolytic vesicular stomatitis virus in pancreatic adenocarcinoma
- (2013) Aaron U. Blackham et al. JOURNAL OF SURGICAL RESEARCH
- PEGylation of Vesicular Stomatitis Virus Extends Virus Persistence in Blood Circulation of Passively Immunized Mice
- (2013) M. Z. Tesfay et al. JOURNAL OF VIROLOGY
- Characteristics of Oncolytic Vesicular Stomatitis Virus Displaying Tumor-Targeting Ligands
- (2013) A. Ammayappan et al. JOURNAL OF VIROLOGY
- Neuroattenuation of Vesicular Stomatitis Virus through Picornaviral Internal Ribosome Entry Sites
- (2013) A. Ammayappan et al. JOURNAL OF VIROLOGY
- Vesicular Stomatitis Virus Variants Selectively Infect and Kill Human Melanomas but Not Normal Melanocytes
- (2013) G. Wollmann et al. JOURNAL OF VIROLOGY
- Histone Deacetylase Inhibitors Potentiate Vesicular Stomatitis Virus Oncolysis in Prostate Cancer Cells by Modulating NF- B-Dependent Autophagy
- (2013) L. Shulak et al. JOURNAL OF VIROLOGY
- Oncolytic Vesicular Stomatitis Virus in an Immunocompetent Model of MUC1-Positive or MUC1-Null Pancreatic Ductal Adenocarcinoma
- (2013) E. Hastie et al. JOURNAL OF VIROLOGY
- Ablation of Nectin4 Binding Compromises CD46 Usage by a Hybrid Vesicular Stomatitis Virus/Measles Virus
- (2013) Y.-P. Liu et al. JOURNAL OF VIROLOGY
- Antifibrotic Properties of Transarterial Oncolytic VSV Therapy for Hepatocellular Carcinoma in Rats With Thioacetamide-Induced Liver Fibrosis
- (2013) Jennifer Altomonte et al. MOLECULAR THERAPY
- Triptolide-Mediated Inhibition of Interferon Signaling Enhances Vesicular Stomatitis Virus-Based Oncolysis
- (2013) Fethia Ben Yebdri et al. MOLECULAR THERAPY
- Amalgamating Oncolytic Viruses to Enhance Their Safety, Consolidate Their Killing Mechanisms, and Accelerate Their Spread
- (2013) Camilo Ayala-Breton et al. MOLECULAR THERAPY
- Suppression of Antiviral Innate Immunity by Sunitinib Enhances Oncolytic Virotherapy
- (2013) Babal K Jha et al. MOLECULAR THERAPY
- BCL-2 Inhibitors Sensitize Therapy-resistant Chronic Lymphocytic Leukemia Cells to VSV Oncolysis
- (2013) Sara Samuel et al. MOLECULAR THERAPY
- Maraba Virus as a Potent Oncolytic Vaccine Vector
- (2013) Jonathan G Pol et al. MOLECULAR THERAPY
- Small cell ovarian carcinoma: genomic stability and responsiveness to therapeutics
- (2013) Lisa F Gamwell et al. Orphanet Journal of Rare Diseases
- Oncolytic vesicular stomatitis virus as a treatment for neuroendocrine tumors
- (2013) Reese W. Randle et al. SURGERY
- Understanding and altering cell tropism of vesicular stomatitis virus
- (2013) Eric Hastie et al. VIRUS RESEARCH
- Model-based rational design of an oncolytic virus with improved therapeutic potential
- (2013) Fabrice Le Bœuf et al. Nature Communications
- Non-replicating rhabdovirus-derived particles (NRRPs) eradicate acute leukemia by direct cytolysis and induction of antitumor immunity
- (2013) C Batenchuk et al. Blood Cancer Journal
- Retargeting Vesicular Stomatitis Virus Glycoprotein Pseudotyped Lentiviral Vectors with Enhanced Stability by In Situ Synthesized Polymer Shell
- (2013) Min Liang et al. Human Gene Therapy Methods
- Safety Studies on Intravenous Administration of Oncolytic Recombinant Vesicular Stomatitis Virus in Purpose-Bred Beagle Dogs
- (2013) Amy K. LeBlanc et al. Human Gene Therapy Clinical Development
- Oncolytic vesicular stomatitis virus quantitatively and qualitatively improves primary CD8+T-cell responses to anticancer vaccines
- (2013) Byram W Bridle et al. OncoImmunology
- Enhanced vesicular stomatitis virus (VSVΔ51) targeting of head and neck cancer in combination with radiation therapy or ZD6126 vascular disrupting agent
- (2012) Nehad M Alajez et al. Cancer Cell International
- Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β
- (2012) S Naik et al. CANCER GENE THERAPY
- Systemic Combination Virotherapy for Melanoma with Tumor Antigen-Expressing Vesicular Stomatitis Virus and Adoptive T-cell Transfer
- (2012) D. M. Rommelfanger et al. CANCER RESEARCH
- The potential of recombinant vesicular stomatitis virus-mediated virotherapy against metastatic colon cancer
- (2012) MINORU YAMAKI et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer
- (2012) E. Hastie et al. JOURNAL OF GENERAL VIROLOGY
- Inhibition of Type I Interferon-Mediated Antiviral Action in Human Glioma Cells by the IKK Inhibitors BMS-345541 and TPCA-1
- (2012) Ziyun Du et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Semireplication-competent vesicular stomatitis virus as a novel platform for oncolytic virotherapy
- (2012) Alexander Muik et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Anti-Fab Aptamers for Shielding Virus from Neutralizing Antibodies
- (2012) Darija Muharemagic et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal Adenocarcinoma
- (2012) A. M. Murphy et al. JOURNAL OF VIROLOGY
- Highly Attenuated Recombinant Vesicular Stomatitis Virus VSV-12'GFP Displays Immunogenic and Oncolytic Activity
- (2012) A. N. van den Pol et al. JOURNAL OF VIROLOGY
- Curative one-shot systemic virotherapy in murine myeloma
- (2012) S Naik et al. LEUKEMIA
- The Efficacy Versus Toxicity Profile of Combination Virotherapy and TLR Immunotherapy Highlights the Danger of Administering TLR Agonists to Oncolytic Virus-treated Mice
- (2012) Diana M Rommelfanger et al. MOLECULAR THERAPY
- Using virally expressed melanoma cDNA libraries to identify tumor-associated antigens that cure melanoma
- (2012) Jose Pulido et al. NATURE BIOTECHNOLOGY
- Acute Reactogenicity after Intramuscular Immunization with Recombinant Vesicular Stomatitis Virus Is Linked to Production of IL-1β
- (2012) Kathleen Athearn et al. PLoS One
- Variation in susceptibility of human malignant melanomas to oncolytic vesicular stomatitis virus
- (2012) Aaron U. Blackham et al. SURGERY
- Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: Role of type I interferon signaling
- (2012) Megan Moerdyk-Schauwecker et al. VIROLOGY
- Electrochemical Sensing of Aptamer-Facilitated Virus Immunoshielding
- (2011) Mahmoud Labib et al. ANALYTICAL CHEMISTRY
- Dynamics of melanoma tumor therapy with vesicular stomatitis virus: explaining the variability in outcomes using mathematical modeling
- (2011) D M Rommelfanger et al. GENE THERAPY
- Retargeting Vesicular Stomatitis Virus Using Measles Virus Envelope Glycoproteins
- (2011) Camilo Ayala-Breton et al. HUMAN GENE THERAPY
- Sensitivity of cervical carcinoma cells to vesicular stomatitis virus-induced oncolysis: Potential role of human papilloma virus infection
- (2011) Fabrice Le Boeuf et al. INTERNATIONAL JOURNAL OF CANCER
- Interferon: Current Status and Future Prospects in Cancer Therapy
- (2011) Ben X. Wang et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Vesicular Stomatitis Virus Expressing Tumor Suppressor p53 Is a Highly Attenuated, Potent Oncolytic Agent
- (2011) J. F. Heiber et al. JOURNAL OF VIROLOGY
- Pseudotyping Vesicular Stomatitis Virus with Lymphocytic Choriomeningitis Virus Glycoproteins Enhances Infectivity for Glioma Cells and Minimizes Neurotropism
- (2011) A. Muik et al. JOURNAL OF VIROLOGY
- Type III IFN Interleukin-28 Mediates the Antitumor Efficacy of Oncolytic Virus VSV in Immune-Competent Mouse Models of Cancer
- (2010) Phonphimon Wongthida et al. CANCER RESEARCH
- Identification of Genetically Modified Maraba Virus as an Oncolytic Rhabdovirus
- (2010) Jan Brun et al. MOLECULAR THERAPY
- Synergistic Interaction Between Oncolytic Viruses Augments Tumor Killing
- (2010) Fabrice Le Boeuf et al. MOLECULAR THERAPY
- VSV Oncolysis in Combination With the BCL-2 Inhibitor Obatoclax Overcomes Apoptosis Resistance in Chronic Lymphocytic Leukemia
- (2010) Sara Samuel et al. MOLECULAR THERAPY
- VSV virotherapy improves chemotherapy by triggering apoptosis due to proteasomal degradation of Mcl-1
- (2009) P Schache et al. GENE THERAPY
- Safety Studies on Intrahepatic or Intratumoral Injection of Oncolytic Vesicular Stomatitis Virus Expressing Interferon-β in Rodents and Nonhuman Primates
- (2009) Nathan Jenks et al. HUMAN GENE THERAPY
- Some Attenuated Variants of Vesicular Stomatitis Virus Show Enhanced Oncolytic Activity against Human Glioblastoma Cells relative to Normal Brain Cells
- (2009) G. Wollmann et al. JOURNAL OF VIROLOGY
- Synergistic antitumor effects of transarterial viroembolization for multifocal hepatocellular carcinoma in rats
- (2008) Jennifer Altomonte et al. HEPATOLOGY
- Chemical targeting of the innate antiviral response by histone deacetylase inhibitors renders refractory cancers sensitive to viral oncolysis
- (2008) T. L.-A. Nguyen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started